Associated Papers
Comprehensive genomic profiling of high-grade serous ovarian carcinoma from Chinese patients identifies co-occurring mutations in the Ras/Raf pathway with TP53.
Zhong F et al.
Cancer Medicine, 2019
In-depth molecular profiling of the biphasic components of uterine carcinosarcomas.
McConechy MK et al.
The Journal of Pathology. Clinical Research, 2015
27499902 (PubMed )
Supplement: CJP2-1-173-s002.xlsx › Sheet1
Molecular profiling of infiltrating urothelial carcinoma of bladder and nonbladder origin.
Millis SZ et al.
Clinical Genitourinary Cancer, 2015
Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer.
Soeda H et al.
International Journal of Clinical Oncology, 2013
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
Janku F et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2012
Select a paper to view details